208 related articles for article (PubMed ID: 29159872)
1. The dark side of glucose transporters in prostate cancer: Are they a new feature to characterize carcinomas?
Gonzalez-Menendez P; Hevia D; Mayo JC; Sainz RM
Int J Cancer; 2018 Jun; 142(12):2414-2424. PubMed ID: 29159872
[TBL] [Abstract][Full Text] [Related]
2. Regulation of GLUT transporters by flavonoids in androgen-sensitive and -insensitive prostate cancer cells.
Gonzalez-Menendez P; Hevia D; Rodriguez-Garcia A; Mayo JC; Sainz RM
Endocrinology; 2014 Sep; 155(9):3238-50. PubMed ID: 24932809
[TBL] [Abstract][Full Text] [Related]
3. Melatonin Decreases Glucose Metabolism in Prostate Cancer Cells: A
Hevia D; Gonzalez-Menendez P; Fernandez-Fernandez M; Cueto S; Rodriguez-Gonzalez P; Garcia-Alonso JI; Mayo JC; Sainz RM
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28933733
[TBL] [Abstract][Full Text] [Related]
4. Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes.
Vaz CV; Marques R; Alves MG; Oliveira PF; Cavaco JE; Maia CJ; Socorro S
J Cancer Res Clin Oncol; 2016 Jan; 142(1):5-16. PubMed ID: 26048031
[TBL] [Abstract][Full Text] [Related]
5. Cellular distribution of Glut-1 and Glut-5 in benign and malignant human prostate tissue.
Reinicke K; Sotomayor P; Cisterna P; Delgado C; Nualart F; Godoy A
J Cell Biochem; 2012 Feb; 113(2):553-62. PubMed ID: 21938742
[TBL] [Abstract][Full Text] [Related]
6. Melatonin uptake through glucose transporters: a new target for melatonin inhibition of cancer.
Hevia D; González-Menéndez P; Quiros-González I; Miar A; Rodríguez-García A; Tan DX; Reiter RJ; Mayo JC; Sainz RM
J Pineal Res; 2015 Mar; 58(2):234-50. PubMed ID: 25612238
[TBL] [Abstract][Full Text] [Related]
7. Diabetes Alters the Expression and Translocation of the Insulin-Sensitive Glucose Transporters 4 and 8 in the Atria.
Maria Z; Campolo AR; Lacombe VA
PLoS One; 2015; 10(12):e0146033. PubMed ID: 26720696
[TBL] [Abstract][Full Text] [Related]
8. Monoethanolamine-induced glucose deprivation promotes apoptosis through metabolic rewiring in prostate cancer.
Garlapati C; Joshi S; Turaga RC; Mishra M; Reid MD; Kapoor S; Artinian L; Rehder V; Aneja R
Theranostics; 2021; 11(18):9089-9106. PubMed ID: 34522228
[No Abstract] [Full Text] [Related]
9. Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile.
Vaz CV; Alves MG; Marques R; Moreira PI; Oliveira PF; Maia CJ; Socorro S
Int J Biochem Cell Biol; 2012 Nov; 44(11):2077-84. PubMed ID: 22964025
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of facilitative glucose transporters in normal and tumour kidney tissues.
Suganuma N; Segade F; Matsuzu K; Bowden DW
BJU Int; 2007 May; 99(5):1143-9. PubMed ID: 17437443
[TBL] [Abstract][Full Text] [Related]
11. Structure, function and regulation of mammalian glucose transporters of the SLC2 family.
Holman GD
Pflugers Arch; 2020 Sep; 472(9):1155-1175. PubMed ID: 32591905
[TBL] [Abstract][Full Text] [Related]
12. Glucose transporters in cancer - from tumor cells to the tumor microenvironment.
Ancey PB; Contat C; Meylan E
FEBS J; 2018 Aug; 285(16):2926-2943. PubMed ID: 29893496
[TBL] [Abstract][Full Text] [Related]
13. Expression and regulation of glucose transporters in the bovine mammary gland.
Zhao FQ; Keating AF
J Dairy Sci; 2007 Jun; 90 Suppl 1():E76-86. PubMed ID: 17517754
[TBL] [Abstract][Full Text] [Related]
14. A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy.
Pertega-Gomes N; Felisbino S; Massie CE; Vizcaino JR; Coelho R; Sandi C; Simoes-Sousa S; Jurmeister S; Ramos-Montoya A; Asim M; Tran M; Oliveira E; Lobo da Cunha A; Maximo V; Baltazar F; Neal DE; Fryer LG
J Pathol; 2015 Aug; 236(4):517-30. PubMed ID: 25875424
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for inhibiting human glucose transporters by exofacial inhibitors.
Wang N; Zhang S; Yuan Y; Xu H; Defossa E; Matter H; Besenius M; Derdau V; Dreyer M; Halland N; He KH; Petry S; Podeschwa M; Tennagels N; Jiang X; Yan N
Nat Commun; 2022 May; 13(1):2632. PubMed ID: 35552392
[TBL] [Abstract][Full Text] [Related]
16. Glucose transporters in the thyroid.
Matsuzu K; Segade F; Wong M; Clark OH; Perrier ND; Bowden DW
Thyroid; 2005 Jun; 15(6):545-50. PubMed ID: 16029120
[TBL] [Abstract][Full Text] [Related]
17. Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment.
Barron CC; Bilan PJ; Tsakiridis T; Tsiani E
Metabolism; 2016 Feb; 65(2):124-39. PubMed ID: 26773935
[TBL] [Abstract][Full Text] [Related]
18. Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival.
Schlößer HA; Drebber U; Urbanski A; Haase S; Baltin C; Berlth F; Neiß S; von Bergwelt-Baildon M; Fetzner UK; Warnecke-Eberz U; Bollschweiler E; Hölscher AH; Mönig SP; Alakus H
Gastric Cancer; 2017 Jan; 20(1):83-91. PubMed ID: 26643879
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth.
Reckzeh ES; Karageorgis G; Schwalfenberg M; Ceballos J; Nowacki J; Stroet MCM; Binici A; Knauer L; Brand S; Choidas A; Strohmann C; Ziegler S; Waldmann H
Cell Chem Biol; 2019 Sep; 26(9):1214-1228.e25. PubMed ID: 31303578
[TBL] [Abstract][Full Text] [Related]
20. Targeting Key Transporters in Tumor Glycolysis as a Novel Anticancer Strategy.
Shi Y; Liu S; Ahmad S; Gao Q
Curr Top Med Chem; 2018; 18(6):454-466. PubMed ID: 29788889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
